Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus

Abstract : Antitumor virotherapy is a developing approach to treat cancer with oncolytic viruses, namely replicative viruses that exclusively or preferentially infect and kill tumor cells. Attenuated strains of Measles Virus (MV) are now being used as oncolytic viruses in clinical trials to treat several types of cancer. The efficacy of oncolytic viruses is mainly due to their capacity to infect and kill tumor cells, but it has also been demonstrated that their capacity to induce immunogenic cell death can activate an antitumor immune response. In this review, we describe the oncolytic capacity of MV and the concept of Immunogenic Cell Death (ICD). We then review how MV induces immunogenic cell death, which can be beneficial for cancer treatment.
Type de document :
Article dans une revue
Journal of Clinical and Cellular Immunology, OMICS Publishing Group, 2015, 6 (1), http://omicsonline.org/open-access/induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.php?aid=38192. 〈10.4172/2155-9899.1000291〉
Liste complète des métadonnées

Littérature citée [101 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01148993
Contributeur : Nicolas Boisgerault <>
Soumis le : mercredi 6 mai 2015 - 10:07:26
Dernière modification le : jeudi 20 septembre 2018 - 17:02:01
Document(s) archivé(s) le : mercredi 19 avril 2017 - 18:20:56

Fichier

induction-of-immunogenic-tumor...
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Carole Achard, Nicolas Boisgerault, Tiphaine Delaunay, Frédéric Tangy, Marc Grégoire, et al.. Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus. Journal of Clinical and Cellular Immunology, OMICS Publishing Group, 2015, 6 (1), http://omicsonline.org/open-access/induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.php?aid=38192. 〈10.4172/2155-9899.1000291〉. 〈inserm-01148993〉

Partager

Métriques

Consultations de la notice

201

Téléchargements de fichiers

165